Drug Profile


Alternative Names: EGIS 5810; GYKI 51189

Latest Information Update: 23 Oct 2001

Price : $50

At a glance

  • Originator IVAX Drug Research Institute
  • Developer Egis Pharmaceuticals; IVAX Drug Research Institute; Japan Tobacco
  • Class Antiepileptic drugs; Anxiolytics; Benzodiazepines; Neuroprotectants; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Major depressive disorder

Most Recent Events

  • 23 Oct 2001 Discontinued-Preclinical for Depression in Japan (Unknown route)
  • 23 Oct 2001 Discontinued-Preclinical for Anxiety disorders in South Korea (Unknown route)
  • 23 Oct 2001 Discontinued-Preclinical for Anxiety disorders in Hungary (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top